Gene: QRICH2
Official Full Name: glutamine rich 2provided by HGNC
Gene Summary: Involved in cell projection assembly; flagellated sperm motility; and negative regulation of ubiquitin-dependent protein catabolic process. Located in sperm flagellum. Implicated in spermatogenic failure 35. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25225 | QRICH2 Knockout cell line (HeLa) | Human | QRICH2 | 1:3~1:6 | Negative | Online Inquiry |
KO25226 | QRICH2 Knockout cell line (HCT 116) | Human | QRICH2 | 1:2~1:4 | Negative | Online Inquiry |
KO25227 | QRICH2 Knockout cell line (HEK293) | Human | QRICH2 | 1:3~1:6 | Negative | Online Inquiry |
QRICH2 Gene Knockout Cell Lines are highly specialized biological tools designed for comprehensive gene function studies and therapeutic exploration. These cell lines are engineered to specifically disrupt the QRICH2 gene, a critical player in various pathways implicated in cellular stress response and disease progression. By providing a reliable model system whereby the QRICH2 gene is inactivated, researchers can investigate the gene's role in pathophysiological processes, allowing for deeper insights into its functions and contributions to cellular homeostasis.
The primary mechanism of action in these knockout cell lines involves the targeted deletion of QRICH2 through advanced CRISPR/Cas9 gene editing technology. This technique facilitates precise genomic modifications, enabling an accurate assessment of the resultant phenotypic variations. Researchers can leverage these changes to elucidate the cellular mechanisms and pathways influenced by QRICH2, providing valuable data that may be instrumental in the development of novel therapeutic strategies.
Scientifically, the QRICH2 Gene Knockout Cell Lines hold significant importance in translational research, particularly in areas such as cancer biology, neurobiology, and metabolic diseases. By understanding the functional dynamics of QRICH2, scientists can uncover potential biomarkers for disease diagnosis or novel drug targets for therapeutic intervention.
What sets these cell lines apart from traditional models is their specificity and the reliability of gene knockout achieved. Unlike transient transfection methods that often result in variable expression levels, these knockout lines offer a stable and reproducible platform, ensuring consistent experimental outcomes. Moreover, the genetic integrity of the cell lines is maintained, which is crucial for longitudinal studies.
For researchers and clinicians, the value of utilizing QRICH2 Gene Knockout Cell Lines lies in their potential to accelerate scientific discovery, facilitate hypothesis testing, and enhance the translational relevance of research findings. By providing a clear window into the biological roles of QRICH2, these cell lines enable users to advance their research endeavors with confidence.
At our company, we pride ourselves on our expertise in gene editing and cell line development, delivering high-quality biological products that empower the scientific community. Our commitment to rigorous validation and customer support ensures that you have the necessary tools to push the boundaries of research and drive innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.